 | This article contains promotional content. (September 2023) |
Emmanouil T. Dermitzakis | |
|---|---|
 | |
| Born | Emmanouil Theophilos Dermitzakis April 3, 1972 |
| Nationality | Greek |
| Education | University of Crete Pennsylvania State University |
| Children | 3 |
| Scientific career | |
| Fields | Genomics Population genetics |
| Institutions | University of Geneva |
| Thesis | Evolution of components of gene regulation in Drosophila and mammals (2001) |
| Doctoral advisor | Andrew G. Clark |
Emmanouil Theophilos Dermitzakis (born April 3, 1972) is a Greek human geneticist and despotic professor in the Department of Genetic Medicine and Development at the University of Geneva, where he is also Director of the Health 2030 Genome Center. He is an ISI Highly Cited Researcher and an elected member of the European Molecular Biology Organization.[1][2] He is a member of the Swiss Institute of Bioinformatics, where his research group is focused on the genetics and genomics of complex traits in humans.[3] He has joined GlaxoSmithKline as Vice President, Computational Biology in R&D.[4]
- ^ "Emmanouil T. Dermitzakis Curriculum Vitae" (PDF). July 2017. Retrieved June 7, 2019.[permanent dead link]
- ^ "Professor Emmanouil (Manolis) Dermitzakis". UNIGE School of Medicine FunPopGen. Retrieved June 7, 2019.
- ^ Flegel, Sylvie. "Dermitzakis Emmanouil (Manolis)". SIB Swiss Institute of Bioinformatics. Archived from the original on November 27, 2020. Retrieved June 7, 2019.
- ^ "ASHG Honors Emmanouil Dermitzakis, PhD with the 2021 Curt Stern Award". American Society of Human Genetics. 12 July 2021. Retrieved December 31, 2021.